Skip to content

Evaluation of the LipiView II Ocular Surface Interferometer

Evaluation of the LipiView II Ocular Surface Interferometer

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022647
Enrollment
Unknown
Registered
2019-04-20
Start date
2019-04-19
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ocular Surface Diseases

Interventions

Case series:LipiView II

Sponsors

Johnson & Johnson Surgical Vision, Inc.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Minimum 18 years old; 2. Availability, willingness, ability and sufficient cognitive awareness to comply with study protocol, examination procedures and visit; 3. Be willing to provide informed consent and authorization to disclose protected health information or equivalent documentation necessary to comply with applicable privacy laws pertaining to medical procedures.

Exclusion criteria

Exclusion criteria: 1. Eyelid abnormality that affects eyelid eversion in either eye; 2. Any of the following ocular conditions in either eye within the past 1 month: ocular surgery, trauma, Herpes infection, eye or eyelid recurrent inflammation or infection, active ocular allergy; 3. Subject is pregnant or lactating; 4. Concurrent participation or participation within 30 days prior to study visit in any other ophthalmic clinical trial involving a therapeutic drug or interventional device; 5. Be an employee, associate or relative of an employee of the clinical study site.

Design outcomes

Primary

MeasureTime frame
Meibomian Gland Image Quality;

Countries

China

Contacts

Public ContactJian Tang

Johnson & Johnson Surgical Vision, Inc.

JTang44@its.jnj.com+86 1520 1810 293

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026